Metropolitan Life Insurance CO Neuronetics, Inc. Transaction History

Metropolitan Life Insurance CO

  • $2.27 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$6.22 - $15.54 $47,956 - $119,813
-7,710 Closed
0 $0
Q2 2021

Jun 21, 2023
BUY
$10.15 - $17.25 $78,256 - $132,997
7,710 New
7,710 $123,000
Q2 2021

Mar 30, 2023
BUY
$10.15 - $17.25 $78,256 - $132,997
7,710 New
7,710 $123,000
Q2 2021

Aug 16, 2021
BUY
$10.15 - $17.25 $78,256 - $132,997
7,710 New
7,710 $124,000

Others Institutions Holding STIM

# of Institutions
68
Shares Held
18.4M
Call Options Held
200
Put Options Held
3.6K
View Full List

About Neuronetics, Inc.

STIM Quotes by TradingView
  • Ticker STIM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,022,800
  • Market Cap $49.7M
  • Description
  • Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...
More about STIM
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email